The 340B Drug Pricing Program was created to help certain healthcare organizations stretch their limited resources to provide more services and reach more patients. Unfortunately, the 340B program has become a profit driver for hospitals and other entities that markup discounted drugs to boost profits, while patients struggle to afford care.
Insurers use copay accumulators and maximizers to prevent copay assistance from counting toward a patient’s out-of-pocket expenses.
People experience health care, treatment, and disease differently because of who they are and where they live.
Non-medical switching is when an insurance company disregards a doctor’s recommendation and forces a patient to change medications for reasons unrelated to health and safety.
PBMs serve as the “middlemen” between drug manufacturers and insurance companies. They control the list of drugs your insurance company covers each year.
You are not alone. Share your story with the Infusion Access Foundation Advocacy Team and hear from other patient champions.
Step therapy, or “fail first,” is when an insurance company requires a patient to try and fail a drug before taking the medication their doctor prescribed.



